Replies to post #14328 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Good to hear Silvr. But 61% not completing the trial was a high rate. Unlike,, Libigel which had a much higher retention rate. I think we might about Libigel this weekend, but I doubt it.

The fact it has been held quiet for so long, is consistent with it being part of a bigger announcement.